Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor

J Med Chem. 2005 Feb 24;48(4):1088-97. doi: 10.1021/jm0491804.

Abstract

In this paper, we describe homology modeling of the alpha1A receptor based on the X-ray structure of bovine rhodopsin. The protein model has been generated by applying ligand-supported homology modeling, using mutational and ligand SAR data to guide the protein modeling procedure. We performed a virtual screening of the company's compound collection to test how well this model is suited to identify alpha1A antagonists. We applied a hierarchical virtual screening procedure guided by 2D filters and three-dimensional pharmacophore models. The ca. 23,000 filtered compounds were docked into the alpha1A homology model with GOLD and scored with PMF. From the top-ranked compounds, 80 diverse compounds were tested in a radioligand displacement assay. 37 compounds revealed K(i) values better than 10 microM; the most active compound binds with 1.4 nM to the alpha1A receptor. Our findings suggest that rhodopsin-based homology models may be used as the structural basis for GPCR lead finding and compound optimization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-1 Receptor Antagonists*
  • Adrenergic alpha-Antagonists / chemistry*
  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Cattle
  • Ligands
  • Models, Molecular
  • Molecular Sequence Data
  • Naphthoquinones / chemistry
  • Piperazines / chemistry
  • Pyridazines / chemistry
  • Pyridines / chemistry
  • Receptors, Adrenergic, alpha-1 / chemistry
  • Rhodopsin / chemistry
  • Sequence Alignment
  • Structure-Activity Relationship

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Adrenergic alpha-Antagonists
  • Ligands
  • Naphthoquinones
  • Piperazines
  • Pyridazines
  • Pyridines
  • Receptors, Adrenergic, alpha-1
  • Rhodopsin